Table 1
Interferon and ribavirin shared care schedule
| Week | ||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 0 | 1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 10 | 12 | 16 | 20 | 24 | 28 | 32 | 36 | 40 | 44 | 48 | |
| ALT, alanine aminotransferase; GP, review by general practitioner; Sp, review by specialist/liver clinic; TSH, thyroid stimulating hormone. | ||||||||||||||||||||
| *Sp treatment to cease under eligibility criteria if PCR is still positive at week 24. | ||||||||||||||||||||
| †Pregnancy test each month during treatment and for six months after treatment is stopped. | ||||||||||||||||||||
| ‡Observations: blood pressure, pulse rate, temperature, weight, side effects. | ||||||||||||||||||||
| NB: In case of common side effects within first three months, liaise with liver clinic/specialist/specialist nurse. | ||||||||||||||||||||
| NB: Review weeks by specialist may be altered to accommodate for changes in client conditions. | ||||||||||||||||||||
| Interferon and ribavirin prescription | Sp | Sp | Sp | Sp | Sp | |||||||||||||||
| Liver function tests (including ALT) | Sp | GP | Sp | Sp | Sp | Sp | Sp | Sp | Sp | Sp | Sp | Sp | Sp | Sp | ||||||
| Full blood count | Sp | GP | GP | GP | Sp | Sp | Sp | Sp | Sp | Sp | Sp | Sp | Sp | Sp | Sp | Sp | ||||
| Thyroid function test | ||||||||||||||||||||
| (TSH and thyroxine) | Sp | Sp | Sp | Sp | Sp | |||||||||||||||
| PCR | Sp | Sp* | Sp | |||||||||||||||||
| Lipids | Sp | Sp | Sp | Sp | Sp | |||||||||||||||
| Urea and electrolytes (including glucose and urate) | Sp | GP | Sp | Sp | Sp | Sp | Sp | Sp | Sp | Sp | Sp | Sp | Sp | Sp | ||||||
| Pregnancy test† | Sp/Gp | Sp/GP | Sp | Sp/GP | Sp | Sp/GP | Sp/GP | Sp | Sp/GP | Sp/GP | Sp | |||||||||
| Gp | GP | |||||||||||||||||||
| Observations‡ | Sp | GP | GP | GP | Sp | Sp | Sp | Sp | Sp | Sp | Sp | Sp | Sp | Sp | Sp | Sp | ||||
